Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-hypnosis plus citalopram for generalized anxiety disorder
IRCT2015091023966N1Phase 3Completed
- Sponsor
- Semnan University
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of citalopram in generalized anxiety disorder (GAD) (2 arms), sponsored by Semnan University. Primary endpoints: State anxiety and Trait anxiety. Started Sep 2013; status: completed.
02
Drugs
citalopram
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on IRCT2015091023966N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015091023966N1.